A long history of clinical experience and of outstanding scientific investigation that extends from bench to bedside has made Mount Sinai synonymous throughout the world with the study and treatment of liver disease. The Division of Liver Diseases was the leading center in the United States for the first effective new oral therapy for liver cancer. Six members of the division’s faculty have served as President of the American Association for the Study of Liver Diseases.
icahn.mssm.edu/departments-and-institutes/medicine/divisions/liver-diseases
US & Canadian Academy of Pathology (USCAP)